Dokploy up to 0.29.12 Git Provider git.ts cloneGitRepository customGitUrl/customGitBranch os command injection
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.0 | $0-$5k | 1.49 |
Summary
A vulnerability classified as critical has been found in Dokploy up to 0.29.12. This impacts the function cloneGitRepository of the file packages/server/src/utils/providers/git.ts of the component Git Provider. The manipulation of the argument customGitUrl/customGitBranch leads to os command injection.
This vulnerability is traded as CVE-2026-72874. It is possible to initiate the attack remotely. There is no exploit available.
Details
A vulnerability was found in Dokploy up to 0.29.12 and classified as critical. This issue affects the function cloneGitRepository of the file packages/server/src/utils/providers/git.ts of the component Git Provider. The manipulation of the argument customGitUrl/customGitBranch with an unknown input leads to a os command injection vulnerability. Using CWE to declare the problem leads to CWE-78. The product constructs all or part of an OS command using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the intended OS command when it is sent to a downstream component. Impacted is confidentiality, integrity, and availability. The summary by CVE is:
Dokploy is a free, self-hostable Platform as a Service (PaaS). Prior to 0.29.13, cloneGitRepository in packages/server/src/utils/providers/git.ts interpolates customGitUrl and customGitBranch into a git clone command passed to execAsync or execAsyncRemote, allowing an authenticated user with application access to execute arbitrary operating system commands on the Dokploy host by setting a malicious custom Git URL and triggering deployment. This issue is fixed in version 0.29.13.
The advisory is shared at github.com. The identification of this vulnerability is CVE-2026-72874 since 08/10/2026. The exploitation is known to be easy. The attack may be initiated remotely. Technical details are known, but no exploit is available. MITRE ATT&CK project uses the attack technique T1202 for this issue.
Upgrading to version 0.29.13 eliminates this vulnerability.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Name
Version
Website
- Product: https://github.com/Dokploy/dokploy/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.3VulDB Meta Temp Score: 6.0
VulDB Base Score: 6.3
VulDB Temp Score: 6.0
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Os command injectionCWE: CWE-78 / CWE-77 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Upgrade: Dokploy 0.29.13
Timeline
08/10/2026 Advisory disclosed08/10/2026 CVE reserved
08/10/2026 VulDB entry created
08/10/2026 VulDB entry last update
Sources
Product: github.comAdvisory: github.com
Status: Confirmed
CVE: CVE-2026-72874 (🔒)
GCVE (CVE): GCVE-0-2026-72874
GCVE (VulDB): GCVE-100-387869
Entry
Created: 08/10/2026 21:30Changes: 08/10/2026 21:30 (57)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.